For securing a higher return-on-investment for all stakeholders, Drugabilis helps its clients by clarifying their needs for addressing pharmaceutical drugability related issues. We provide them with the required expertise and give them access to dedicated experimental capabilities. Thus, Drugabilis accelerates the selection of higher value drug candidates that will more rapidly complete the early development studies and smoothly reach clinical Proof-of Concept studies.
Latest news
2024 AFSSI Connexions
Back to the images of the 2024 AFSSI Connexions in Montpellier (2nd and 3rd of July)... Like last...
more news>
useful ressources
job offers/application
contact us